Chapter 49: Problem 5
What is the difference between biomarker and risk marker?
Short Answer
Step by step solution
Key Concepts
These are the key concepts you need to understand to accurately answer the question.
Chapter 49: Problem 5
What is the difference between biomarker and risk marker?
These are the key concepts you need to understand to accurately answer the question.
All the tools & learning materials you need for study success - in one app.
Get started for freeWhat are the approaches used in the development of clinical proteomics?
Weakness of 2-dimensional SDS-PAGE is: a. lack of superior reproducibility b. lack of protection of proteins from structural destabilization c. inability of obtaining protein sequencing data d. lack of superior methods of protein labeling
Commercially available antibody arrays technology has many of the same problems observed with genomics because of problems associated with: a. data analysis, interpretation, storage, and retrieval b. high background created by not well developed reagents c. necessity of using radioactive materials d. inaccuracy of chips readers
What is proteomics?
While planning proteomics experiments, a researcher should: a. have available all types of mass spectrometers b. mandatory access to protein microarrays c. be aware of strength and weaknesses of each technology d. always be an expert in statistics and computer programming for solving problems associated with bioinformatics
What do you think about this solution?
We value your feedback to improve our textbook solutions.